445303-12-8

Basic information

• Product Name: 2-(2,3-DIHYDROBENZOFURAN-6-YL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE
• Synonyms: 2-(2,3-DIHYDROBENZOFURAN-6-YL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE
• CAS NO: 445303-12-8
• Molecular Formula: C14H19BO3
• Molecular Weight: 246.12
• Mol File: 445303-12-8.mol

Chemical Properties

• Boiling Point: 342.6±31.0 °C(Predicted)
• Appearance: /
• Density: 1.09±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-(2,3-DIHYDROBENZOFURAN-6-YL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2,3-DIHYDROBENZOFURAN-6-YL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE(445303-12-8)
• EPA Substance Registry System: 2-(2,3-DIHYDROBENZOFURAN-6-YL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE(445303-12-8)

Safety Data

• Hazardous Substances Data: 445303-12-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Synthesis:
2-(2,3-DIHYDROBENZOFURAN-6-YL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE is used as a reagent in the synthesis of pharmaceuticals for its ability to create carbon-carbon bonds, which are essential in the development of new drug molecules.
Used in Agrochemical Synthesis:
In the agrochemical industry, 2-(2,3-DIHYDROBENZOFURAN-6-YL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE is used as a reagent to form carbon-carbon bonds in the synthesis of new agrochemical compounds, contributing to the development of effective and environmentally friendly pesticides and fertilizers.
Used in Advanced Material Synthesis:
2-(2,3-DIHYDROBENZOFURAN-6-YL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE is utilized as a reagent in the synthesis of advanced materials, where its ability to form stable and selective carbon-carbon bonds is crucial for creating innovative materials with enhanced properties.
Used in Electronic and Optoelectronic Material Development:
In the field of electronics and optoelectronics, 2-(2,3-DIHYDROBENZOFURAN-6-YL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE is used as a component in the development of new materials, leveraging its boron functionality to create materials with improved electronic and optoelectronic properties.

Upstream product

• 73183-34-3 bis(pinacol)diborane 
• 128851-73-0 6-bromo-benzofuran 
• 934329-77-8 2-(benzofuran-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 

Relevant articles and documents

PYRIMIDINE SULFAMIDE DERIVATIVE AND PREPARATION METHOD AND MEDICAL APPLICATION THEREOF

Disclosed are a series of pyrimidine sulfamide compounds and applications thereof in preparing a drug for a disease related to an ETA receptor antagonist. In particular, disclosed is a derived compound represented by formula (I) or a tautomer or pharmaceutically acceptable composition thereof.

Condensed derivatives of imidazole useful as pharmaceuticals

The invention relates to the compounds (I) and their acids and bases salts: wherein: the dotted line indicates a double bond; X is N or C-R1 and Y is N or C-R2, X and Y not being simultaneously N; A is selected from the group consisting of phenyl, naphthyl and (5-11) membered monocyclic or bicyclic unsaturated cycle or heterocycle possibly substituted as defined in the application, and A can also comprise either a further (4-7) membered heterocycle, said heterocycle being a monocycle, fused, saturated or unsaturated, the polycyclic system then comprising up to 14 members and up to 5 heteroatoms selected from N, O and S; B is Hydrogen or a substituent as defined in the application, or B is a (4-10) membered mono or bicyclic saturated or unsaturated heterocycle containing 1-3 heteroatoms selected from N, O and S, and possibly substituted as defined in the application; B not being Hydrogen when X is N and Y is C-R2; R1 is Hydrogen or a substituent as defined in the application; B and R1 cannot be simultaneously Hydrogen; R2 is Hydrogen or Halogen; their preparation, their use in the antibacterial prevention and therapy, alone or in association with antibacterials, antivirulence agents or drugs reinforcing the host innate immunity, and pharmaceutical compositions and associations containing them.

NEW COMPOUNDS

This invention relates to novel compounds having the structural formula I below: and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.